Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1963 3
1964 5
1965 9
1966 10
1967 6
1968 14
1969 11
1970 13
1971 6
1972 6
1973 6
1974 6
1975 7
1976 5
1977 5
1978 7
1979 12
1980 10
1981 13
1982 17
1983 21
1984 24
1985 20
1986 19
1987 14
1988 13
1989 14
1990 17
1991 26
1992 16
1993 17
1994 20
1995 34
1996 18
1997 14
1998 22
1999 25
2000 27
2001 19
2002 23
2003 23
2004 19
2005 29
2006 23
2007 32
2008 26
2009 38
2010 29
2011 30
2012 37
2013 29
2014 29
2015 35
2016 29
2017 38
2018 40
2019 36
2020 36
2021 43
2022 43
2023 33
2024 27
2025 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,213 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV Jr, Dieleman LA, Katz S, Rutgeerts P; UNITI–IM-UNITI Study Group. Feagan BG, et al. Among authors: blank ma. N Engl J Med. 2016 Nov 17;375(20):1946-1960. doi: 10.1056/NEJMoa1602773. N Engl J Med. 2016. PMID: 27959607 Free article. Clinical Trial.
Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1.
Janssen M, Schmidt C, Bruch PM, Blank MF, Rohde C, Waclawiczek A, Heid D, Renders S, Göllner S, Vierbaum L, Besenbeck B, Herbst SA, Knoll M, Kolb C, Przybylla A, Weidenauer K, Ludwig AK, Fabre M, Gu M, Schlenk RF, Stölzel F, Bornhäuser M, Röllig C, Platzbecker U, Baldus C, Serve H, Sauer T, Raffel S, Pabst C, Vassiliou G, Vick B, Jeremias I, Trumpp A, Krijgsveld J, Müller-Tidow C, Dietrich S. Janssen M, et al. Among authors: blank mf. Blood. 2022 Dec 15;140(24):2594-2610. doi: 10.1182/blood.2021014241. Blood. 2022. PMID: 35857899 Free article.
[No title available]
Blank M. Blank M. Pathophysiology. 2009 Aug;16(2-3):67-9. doi: 10.1016/j.pathophys.2009.02.002. Epub 2009 Mar 4. Pathophysiology. 2009. PMID: 19264462 Free article. No abstract available.
The seven faces of SIRT7.
Blank MF, Grummt I. Blank MF, et al. Transcription. 2017 Mar 15;8(2):67-74. doi: 10.1080/21541264.2016.1276658. Epub 2017 Jan 9. Transcription. 2017. PMID: 28067587 Free PMC article. Review.
Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells.
Pauli C, Kienhöfer M, Blank MF, Begik O, Rohde C, Zimmermann SMN, Werner L, Heid D, Xu F, Weidenauer K, Delaunay S, Krall N, Trunk K, Zhao D, Zhou F, Llovera L, Ollivier A, Heit-Mondrzyk A, Platzbecker U, Baldus C, Serve H, Bornhäuser M, Vågbø CB, Benitah SA, Krijgsveld J, Novoa EM, Müller-Tidow C, Frye M. Pauli C, et al. Among authors: blank mf. Blood. 2025 Nov 13;146(20):2443-2456. doi: 10.1182/blood.2024027822. Blood. 2025. PMID: 40749163 Free article.
Population genomics of post-glacial western Eurasia.
Allentoft ME, Sikora M, Refoyo-Martínez A, Irving-Pease EK, Fischer A, Barrie W, Ingason A, Stenderup J, Sjögren KG, Pearson A, Sousa da Mota B, Schulz Paulsson B, Halgren A, Macleod R, Jørkov MLS, Demeter F, Sørensen L, Nielsen PO, Henriksen RA, Vimala T, McColl H, Margaryan A, Ilardo M, Vaughn A, Fischer Mortensen M, Nielsen AB, Ulfeldt Hede M, Johannsen NN, Rasmussen P, Vinner L, Renaud G, Stern A, Jensen TZT, Scorrano G, Schroeder H, Lysdahl P, Ramsøe AD, Skorobogatov A, Schork AJ, Rosengren A, Ruter A, Outram A, Timoshenko AA, Buzhilova A, Coppa A, Zubova A, Silva AM, Hansen AJ, Gromov A, Logvin A, Gotfredsen AB, Henning Nielsen B, González-Rabanal B, Lalueza-Fox C, McKenzie CJ, Gaunitz C, Blasco C, Liesau C, Martinez-Labarga C, Pozdnyakov DV, Cuenca-Solana D, Lordkipanidze DO, En'shin D, Salazar-García DC, Price TD, Borić D, Kostyleva E, Veselovskaya EV, Usmanova ER, Cappellini E, Brinch Petersen E, Kannegaard E, Radina F, Eylem Yediay F, Duday H, Gutiérrez-Zugasti I, Merts I, Potekhina I, Shevnina I, Altinkaya I, Guilaine J, Hansen J, Aura Tortosa JE, Zilhão J, Vega J, Buck Pedersen K, Tunia K, Zhao L, Mylnikova LN, Larsson L, Metz L, Yepiskoposyan L, Pedersen L, Sarti L, O… See abstract for full author list ➔ Allentoft ME, et al. Among authors: blank m. Nature. 2024 Jan;625(7994):301-311. doi: 10.1038/s41586-023-06865-0. Epub 2024 Jan 10. Nature. 2024. PMID: 38200295 Free PMC article.
The ribosomal protein S6 kinase alpha-1 (RPS6KA1) induces resistance to venetoclax/azacitidine in acute myeloid leukemia.
Weidenauer K, Schmidt C, Rohde C, Pauli C, Blank MF, Heid D, Waclawiczek A, Corbacioglu A, Göllner S, Lotze M, Vierbaum L, Renders S, Krijgsveld J, Raffel S, Sauer T, Trumpp A, Pabst C, Müller-Tidow C, Janssen M. Weidenauer K, et al. Among authors: blank mf. Leukemia. 2023 Aug;37(8):1611-1625. doi: 10.1038/s41375-023-01951-8. Epub 2023 Jul 6. Leukemia. 2023. PMID: 37414921 Free PMC article.
Adjuvants and autoimmunity.
Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Israeli E, et al. Among authors: blank m. Lupus. 2009 Nov;18(13):1217-25. doi: 10.1177/0961203309345724. Lupus. 2009. PMID: 19880572 Review.
1,213 results